StockData
Valneva SE logo

Valneva SE (VALN) stock

VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 17, 2026Score 1/30
$5.57−0.08 (-1.50%)

Close on Nov 17, 2026Market cap $482.87MP/E –Yield –

Valneva total assets

Total assets on the balance sheet at the end of each period.

Valneva's total assets was €388.28M at Jun 30, 2026. For fiscal 2025 it was €398.84M, down 20.2% from the year before. The highest annual figure on record is €817.35M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025€398.84M-20.2%
FY2024Dec 31, 2024€500.03M+8.7%
FY2023Dec 31, 2023€460.06M-26.0%
FY2022Dec 31, 2022€621.34M-24.0%
FY2021Dec 31, 2021€817.35M+82.0%
FY2020Dec 31, 2020€449.16M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€388.28M-17.8%
Q1 FY2026Mar 31, 2026€372.01M-22.9%
Q4 FY2025Dec 31, 2025€398.84M-20.2%
Q3 FY2025Sep 30, 2025€448.23M-13.2%
Q2 FY2025Jun 30, 2025€472.63M+1.3%
Q1 FY2025Mar 31, 2025€482.24M-4.1%
Q4 FY2024Dec 31, 2024€500.03M+8.7%
Q3 FY2024Sep 30, 2024€516.61M-0.8%
Q2 FY2024Jun 30, 2024€466.57M-14.0%
Q1 FY2024Mar 31, 2024€502.83M-14.8%
Q4 FY2023Dec 31, 2023€460.06M-26.0%
Q3 FY2023Sep 30, 2023€520.54M-25.4%
Q2 FY2023Jun 30, 2023€542.57M-25.2%
Q1 FY2023Mar 31, 2023€590.00M-24.1%
Q4 FY2022Dec 31, 2022€621.34M-24.0%
Q3 FY2022Sep 30, 2022€698.08M+55.4%
Q2 FY2022Jun 30, 2022€725.11M–
Q1 FY2022Mar 31, 2022€777.71M–
Q4 FY2021Dec 31, 2021€817.35M–
Q4 FY2020Dec 31, 2020€449.16M–

More Valneva figures

See a number that looks wrong?